Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
29.73
+0.29 (0.99%)
At close: Mar 9, 2026, 4:00 PM EDT
30.22
+0.49 (1.65%)
After-hours: Mar 9, 2026, 7:41 PM EDT
Enliven Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,778 | 914 | 1,099 | 570 | - | - | |
| Market Cap Growth | 69.48% | -16.86% | 92.74% | - | - | - | |
| Enterprise Value | 1,316 | 437 | 808 | 307 | - | - | |
| Last Close Price | 29.73 | 15.40 | 22.50 | 13.84 | - | - | |
| PB Ratio | 3.84 | 1.99 | 3.55 | 2.32 | - | - | |
| P/TBV Ratio | 3.87 | 1.99 | 3.55 | 2.32 | - | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | - | 0.00 | 0.01 | 0.00 | |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.01 | -1.03 | -1.03 | -1.03 | |
| Net Debt / EBITDA Ratio | 3.87 | 3.87 | 3.01 | 3.09 | 1.94 | 4.46 | |
| Net Debt / FCF Ratio | 6.56 | 6.56 | 4.28 | 4.12 | 2.29 | 5.69 | |
| Quick Ratio | 27.92 | 27.92 | 19.70 | 9.78 | 7.78 | 19.13 | |
| Current Ratio | 28.66 | 28.66 | 19.99 | 10.28 | 8.00 | 19.24 | |
| Return on Equity (ROE) | -26.95% | -26.95% | -32.04% | -44.90% | -41.90% | -20.94% | |
| Return on Assets (ROA) | -18.65% | -18.65% | -21.87% | -28.94% | -24.66% | -12.67% | |
| Return on Capital Employed (ROCE) | -26.00% | -26.00% | -33.70% | -33.40% | -52.70% | -23.00% | |
| Earnings Yield | -5.83% | -11.35% | -8.10% | -12.55% | - | - | |
| FCF Yield | -3.96% | -7.71% | -6.66% | -10.77% | - | - | |
| Buyback Yield / Dilution | -20.38% | -20.38% | -32.43% | -1037.74% | 60.02% | -56.70% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.